山东大学教师主页 Yingjie Zhang Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer Home

Personal Information

Degree:Doctoral Degree in Medicine
Status:Employed
School/Department:药学院

Gender:Male

Education Level:Postgraduate (Doctoral)

Alma Mater:山东大学

Current position: Home / Scientific Research / Paper Publications

Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity

Release Time:2023-10-29 | Hits:

Institution:药学院

Title of Paper:Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity

Journal:J. Med. Chem.

Document Code:D772917E21A84BDB997CA26E1776A6A0

Volume:66

Issue:14

Page Number:10080

Number of Words:1

Translation or Not:No

Date of Publication:2023-07